$TNET
TRINET GROUP, INC. Stock $tnet

$tnet Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000093709824000088 Filed on April 26, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$1.226B	$1.264B	$1.246B
YoY Change	1.41%	1.44%	2.3%
Cost Of Revenue	$991.0M	$986.0M	$930.0M
YoY Change	4.65%	6.02%	4.14%
Gross Profit	$235.0M	$278.0M	$316.0M
YoY Change	-10.31%	-12.03%	-2.77%
Gross Profit Margin	19.17%	21.99%	25.36%
Selling, General & Admin	$119.0M	$120.0M	$112.0M
YoY Change	-8.46%	7.14%	21.74%
% of Gross Profit	50.64%	43.17%	35.44%
Research & Development	$17.00M	$18.00M	$17.00M
YoY Change	0.0%	5.88%	6.25%
% of Gross Profit	7.23%	6.47%	5.38%
Depreciation & Amortization	$19.00M	$18.00M	$30.00M
YoY Change	216.67%	-40.0%	42.86%
% of Gross Profit	8.09%	6.47%	9.49%
Operating Expenses	$136.0M	$156.0M	$129.0M
YoY Change	-17.58%	20.93%	19.44%
Operating Profit	$80.00M	$122.0M	$169.0M
YoY Change	-17.53%	-27.81%	-17.16%
Interest Expense	$1.000M	$2.000M	$11.00M
YoY Change	-92.86%	-81.82%	-375.0%
% of Operating Profit	1.25%	1.64%	6.51%
Other Income/Expense, Net
YoY Change
Pretax Income	$81.00M	$124.0M	$180.0M
YoY Change	-27.03%	-31.11%	-10.0%
Income Tax	$21.00M	$33.00M	$49.00M
% Of Pretax Income	25.93%	26.61%	27.22%
Net Earnings	$60.00M	$91.00M	$131.0M
YoY Change	-27.71%	-30.53%	-10.27%
Net Earnings / Revenue	4.89%	7.2%	10.51%
Basic Earnings Per Share	$1.21	$1.80	$2.18
Diluted Earnings Per Share	$1.20	$1.78	$2.17
COMMON SHARES
Basic Shares Outstanding	50.56M shares	50.57M shares	59.98M shares
Diluted Shares Outstanding	51.00M shares	51.00M shares	60.00M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$249.0M	$383.0M	$796.0M
YoY Change	-54.81%	-51.88%	104.63%
Cash & Equivalents	$177.0M	$298.0M	$707.0M
Short-Term Investments	$72.00M	$85.00M	$89.00M
Other Short-Term Assets	$48.00M	$1.979B	$44.00M
YoY Change	-96.14%	4397.73%	-58.49%
Inventory
Prepaid Expenses	$76.00M	$79.00M	$85.00M
Receivables	$15.00M	$478.0M	$15.00M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.566B	$2.840B	$2.629B
YoY Change	17.87%	8.03%	25.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.00M	$37.00M	$31.00M
YoY Change	-75.0%	19.35%	-62.2%
Goodwill	$462.0M	$462.0M	$462.0M
YoY Change	0.0%	0.0%	6.7%
Intangibles	$176.0M	$174.0M	$155.0M
YoY Change	12.82%	12.26%	55.0%
Long-Term Investments	$156.0M	$161.0M	$142.0M
YoY Change	6.85%	13.38%	-13.94%
Other Assets	$145.0M	$294.0M	$133.0M
YoY Change	-50.51%	121.05%	10.83%
Total Long-Term Assets	$1.137B	$1.128B	$1.107B
YoY Change	2.16%	1.9%	-0.36%
TOTAL ASSETS
Total Short-Term Assets	$2.566B	$2.840B	$2.629B
Total Long-Term Assets	$1.137B	$1.128B	$1.107B
Total Assets	$3.703B	$3.968B	$3.736B
YoY Change	12.55%	6.21%	16.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$85.00M	$122.0M	$130.0M
YoY Change	-15.0%	-6.15%	10.17%
Accrued Expenses	$2.217B	$2.380B	$1.662B
YoY Change	45.95%	43.2%	8.7%
Deferred Revenue	$70.00M	$51.00M	$131.0M
YoY Change	-10.26%	-61.07%	5.65%
Short-Term Debt	$84.00M	$109.0M	$295.0M
YoY Change		-63.05%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.463B	$2.669B	$2.235B
YoY Change	44.29%	19.42%	25.0%
LONG-TERM LIABILITIES
Long-Term Debt	$984.0M	$984.0M	$496.0M
YoY Change	98.39%	98.39%	0.2%
Other Long-Term Liabilities	$12.00M	$159.0M	$8.000M
YoY Change	-92.73%	1887.5%	-11.11%
Total Long-Term Liabilities	$996.0M	$1.143B	$504.0M
YoY Change	50.68%	126.79%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.463B	$2.669B	$2.235B
Total Long-Term Liabilities	$996.0M	$1.143B	$504.0M
Total Liabilities	$3.603B	$3.825B	$2.911B
YoY Change	51.71%	31.4%	16.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$916.0M	-$848.0M	-$83.00M
YoY Change	6946.15%	921.69%	-37.59%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$100.0M	$143.0M	$825.0M
YoY Change
Total Liabilities & Shareholders Equity	$3.703B	$3.968B	$3.736B
YoY Change	12.55%	6.21%	16.6%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$60.00M	$91.00M	$131.0M
YoY Change	-27.71%	-30.53%	-10.27%
Depreciation, Depletion And Amortization	$19.00M	$18.00M	$30.00M
YoY Change	216.67%	-40.0%	42.86%
Cash From Operating Activities	-$123.0M	-$122.0M	-$77.00M
YoY Change	-185.42%	58.44%	-135.98%
INVESTING ACTIVITIES
Capital Expenditures	$17.00M	$18.00M	$17.00M
YoY Change	0.0%	5.88%	54.55%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$15.00M	-$29.00M	-$6.000M
YoY Change	66.67%	383.33%	-97.03%
Cash From Investing Activities	-$2.000M	-$47.00M	-$23.00M
YoY Change	-75.0%	104.35%	-89.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$200.0M
YoY Change
Cash From Financing Activities	-148.0M	-30.00M	$200.0M
YoY Change	-50.67%	-115.0%	-156.66%
NET CHANGE
Cash From Operating Activities	-123.0M	-122.0M	-$77.00M
Cash From Investing Activities	-2.000M	-47.00M	-$23.00M
Cash From Financing Activities	-148.0M	-30.00M	$200.0M
Net Change In Cash	-273.0M	-199.0M	$100.0M
YoY Change	66.46%	-299.0%	-128.41%
FREE CASH FLOW
Cash From Operating Activities	-$123.0M	-$122.0M	-$77.00M
Capital Expenditures	$17.00M	$18.00M	$17.00M
Free Cash Flow	-$140.0M	-$140.0M	-$94.00M
YoY Change	-210.24%	48.94%	-146.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1264000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1246000000	usd
CY2024Q1	us-gaap	Operating Insurance And Claims Costs Production OperatingInsuranceAndClaimsCostsProduction	907000000	usd
CY2023Q1	us-gaap	Operating Insurance And Claims Costs Production OperatingInsuranceAndClaimsCostsProduction	852000000	usd
CY2024Q1	tnet	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization And Operating Insurance And Claims Costs Production CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction	79000000	usd
CY2023Q1	tnet	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization And Operating Insurance And Claims Costs Production CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction	78000000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	72000000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	69000000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48000000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	43000000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18000000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17000000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	18000000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	18000000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	1142000000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	1077000000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	122000000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	169000000	usd
CY2024Q1	tnet	Interest Expense Bank Fees And Other InterestExpenseBankFeesAndOther	16000000	usd
CY2023Q1	tnet	Interest Expense Bank Fees And Other InterestExpenseBankFeesAndOther	7000000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	18000000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	18000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	124000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	180000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	91000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	131000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	88000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	134000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.80
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.18
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.78
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.17
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60000000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60000000	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	298000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	287000000	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	85000000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	65000000	usd
CY2024Q1	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	1059000000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	1269000000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11000000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18000000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	467000000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	447000000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	79000000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	67000000	usd
CY2024Q1	tnet	Other Payroll Assets Current OtherPayrollAssetsCurrent	791000000	usd
CY2023Q4	tnet	Other Payroll Assets Current OtherPayrollAssetsCurrent	381000000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	50000000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	44000000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	2840000000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2578000000	usd
CY2024Q1	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	152000000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	158000000	usd
CY2024Q1	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	161000000	usd
CY2023Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	143000000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17000000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22000000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	24000000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	462000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	462000000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	174000000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	172000000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	142000000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	139000000	usd
CY2024Q1	us-gaap	Assets Assets	3968000000	usd
CY2023Q4	us-gaap	Assets Assets	3693000000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	122000000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	87000000	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	109000000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	109000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	51000000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	65000000	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	537000000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	515000000	usd
CY2024Q1	tnet	Collateral Paid To Insurance Carriers Net Of Health Benefit Loss Reserves Current CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent	167000000	usd
CY2023Q4	tnet	Collateral Paid To Insurance Carriers Net Of Health Benefit Loss Reserves Current CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent	175000000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	51000000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	50000000	usd
CY2024Q1	tnet	Accrued Payroll Tax Liabilities And Other Payroll Withholdings AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings	1611000000	usd
CY2023Q4	tnet	Accrued Payroll Tax Liabilities And Other Payroll Withholdings AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings	1438000000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14000000	usd
CY2024Q1	tnet	Insurance Premiums And Other Payables InsurancePremiumsAndOtherPayables	7000000	usd
CY2023Q4	tnet	Insurance Premiums And Other Payables InsurancePremiumsAndOtherPayables	10000000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2669000000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2463000000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	984000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	984000000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	120000000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	120000000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	13000000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	13000000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30000000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12000000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5000000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	3825000000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3615000000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.000025
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.000025
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	996000000	usd
CY2023Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	976000000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000025
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000025
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50573176	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50573176	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50664471	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50664471	shares
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-848000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-896000000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	143000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	78000000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3968000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3693000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	78000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	775000000	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	13000000	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	0	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	143000000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	825000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	91000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	131000000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18000000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18000000	usd
CY2024Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	11000000	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	12000000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2000000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2000000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	20000000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11000000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3000000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	20000000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-5000000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	12000000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	14000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	21000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	10000000	usd
CY2024Q1	tnet	Increase Decrease In Other Payroll Assets IncreaseDecreaseInOtherPayrollAssets	410000000	usd
CY2023Q1	tnet	Increase Decrease In Other Payroll Assets IncreaseDecreaseInOtherPayrollAssets	180000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	20000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	30000000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-14000000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	25000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	23000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-21000000	usd
CY2024Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	-7000000	usd
CY2023Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	-5000000	usd
CY2024Q1	us-gaap	Increase Decrease In Workers Compensation Liabilities IncreaseDecreaseInWorkersCompensationLiabilities	1000000	usd
CY2023Q1	us-gaap	Increase Decrease In Workers Compensation Liabilities IncreaseDecreaseInWorkersCompensationLiabilities	-1000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	173000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-80000000	usd
CY2024Q1	tnet	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-4000000	usd
CY2023Q1	tnet	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-4000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-122000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-77000000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	95000000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	82000000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	66000000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	76000000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18000000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-47000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23000000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	23000000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	91000000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7000000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4000000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	495000000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	200000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-30000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	200000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-199000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	100000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1466000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1537000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1267000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1637000000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	26000000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	11000000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7000000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4000000	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	13000000	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	0	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3000000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5000000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect certain reported amounts and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates are based on historical experience and on various other assumptions that we believe to be reasonable from the facts available to us. Some of the assumptions are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our condensed consolidated financial statements could be materially affected.</span></div>
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	75000000	usd
CY2024Q1	tnet	Revenue Remaining Performance Obligation Provision RevenueRemainingPerformanceObligationProvision	0	usd
CY2023Q1	tnet	Revenue Remaining Performance Obligation Provision RevenueRemainingPerformanceObligationProvision	0	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	7000000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	8000000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	7000000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	67000000	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	65000000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	58000000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	298000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	287000000	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	85000000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	65000000	usd
CY2024Q1	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	1059000000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	1269000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	161000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	143000000	usd
CY2024Q1	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	1755000000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	1922000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	113000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	347000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	10000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	18000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	488000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	39000000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	32000000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	27000000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	44000000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	66000000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	76000000	usd
CY2024Q1	us-gaap	Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the accrued workers’ compensation cost activity for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accrued costs, beginning of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incurred</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(12)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187 </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes workers' compensation liabilities on the condensed consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral paid to carriers and offset against accrued costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in less than 1 year<br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> and $1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">at March 31, 2024 and December 31, 2023, respectively)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in more than 1 year <br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> and $4 at March 31, 2024 and December 31, 2023, respectively)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170 </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div>
CY2023Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments	175000000	usd
CY2022Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments	189000000	usd
CY2024Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	16000000	usd
CY2023Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	16000000	usd
CY2024Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-4000000	usd
CY2023Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-6000000	usd
CY2024Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	12000000	usd
CY2023Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	10000000	usd
CY2024Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	1000000	usd
CY2023Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	1000000	usd
CY2024Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	11000000	usd
CY2023Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	11000000	usd
CY2024Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	12000000	usd
CY2023Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	12000000	usd
CY2024Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments	175000000	usd
CY2023Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments	187000000	usd
CY2024Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments	175000000	usd
CY2023Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments	175000000	usd
CY2024Q1	tnet	Liability For Unpaid Claims And Claims Adjustment Expense Collateral LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral	4000000	usd
CY2023Q4	tnet	Liability For Unpaid Claims And Claims Adjustment Expense Collateral LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral	5000000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	171000000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	170000000	usd
CY2024Q1	tnet	Collateral Paid To Insurance Carriers Net Of Workers Compensation Loss Reserves Current CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent	1000000	usd
CY2023Q4	tnet	Collateral Paid To Insurance Carriers Net Of Workers Compensation Loss Reserves Current CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent	1000000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	51000000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	50000000	usd
CY2024Q1	tnet	Collateral Paid To Insurance Carriers Net Of Workers Compensation Loss Reserves Noncurrent CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent	3000000	usd
CY2023Q4	tnet	Collateral Paid To Insurance Carriers Net Of Workers Compensation Loss Reserves Noncurrent CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent	4000000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	120000000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	120000000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	171000000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	170000000	usd
CY2024Q1	tnet	Collateral Held By Insurance Carriers CollateralHeldByInsuranceCarriers	31000000	usd
CY2023Q4	tnet	Collateral Held By Insurance Carriers CollateralHeldByInsuranceCarriers	32000000	usd
CY2024Q1	tnet	Liability For Unpaid Claims And Claims Adjustment Expense Collateral LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral	4000000	usd
CY2023Q4	tnet	Liability For Unpaid Claims And Claims Adjustment Expense Collateral LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral	5000000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20000000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11000000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1000000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1000000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50664471	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50664471	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60555661	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60555661	shares
CY2024Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	197872	shares
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1157871	shares
CY2024Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	59249	shares
CY2023Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	49701	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50573176	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50573176	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59522954	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59522954	shares
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	409000000	usd
CY2024Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	2715000000	usd
CY2024Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.25
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	13000000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.27
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.27
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	91000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	131000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60000000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.80
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.18
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	91000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	131000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60000000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60000000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.78
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.17
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000937098-24-000088-index-headers.html	Edgar Link	pending
0000937098-24-000088-index.html	Edgar Link	pending
0000937098-24-000088.txt	Edgar Link	pending
0000937098-24-000088-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tnet-033124xexhibit311.htm	Edgar Link	pending
tnet-033124xexhibit312.htm	Edgar Link	pending
tnet-033124xexhibit321.htm	Edgar Link	pending
tnet-20240331.htm	Edgar Link	pending
tnet-20240331.xsd	Edgar Link	pending
tnet-20240331_g1.jpg	Edgar Link	pending
tnet-20240331_g10.jpg	Edgar Link	pending
tnet-20240331_g11.jpg	Edgar Link	pending
tnet-20240331_g12.jpg	Edgar Link	pending
tnet-20240331_g13.jpg	Edgar Link	pending
tnet-20240331_g14.jpg	Edgar Link	pending
tnet-20240331_g15.jpg	Edgar Link	pending
tnet-20240331_g16.jpg	Edgar Link	pending
tnet-20240331_g17.jpg	Edgar Link	pending
tnet-20240331_g18.jpg	Edgar Link	pending
tnet-20240331_g19.jpg	Edgar Link	pending
tnet-20240331_g2.jpg	Edgar Link	pending
tnet-20240331_g20.jpg	Edgar Link	pending
tnet-20240331_g21.jpg	Edgar Link	pending
tnet-20240331_g22.jpg	Edgar Link	pending
tnet-20240331_def.xml	Edgar Link	unprocessable
tnet-20240331_g23.jpg	Edgar Link	pending
tnet-20240331_g24.jpg	Edgar Link	pending
tnet-20240331_g25.jpg	Edgar Link	pending
tnet-20240331_g3.jpg	Edgar Link	pending
tnet-20240331_g4.jpg	Edgar Link	pending
tnet-20240331_g5.jpg	Edgar Link	pending
tnet-20240331_g6.jpg	Edgar Link	pending
tnet-20240331_g7.jpg	Edgar Link	pending
tnet-20240331_g8.jpg	Edgar Link	pending
tnet-20240331_g9.jpg	Edgar Link	pending
tnet-20240331_htm.xml	Edgar Link	completed
tnet-20240331_cal.xml	Edgar Link	unprocessable
tnet-20240331_pre.xml	Edgar Link	unprocessable
tnet-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TNET
TRINET GROUP, INC. Stock $tnet

2024 Q2 Form 10-Q Financial Statement

#000093709824000088 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TNET TRINET GROUP, INC. Stock $tnet

2024 Q2 Form 10-Q Financial Statement

#000093709824000088 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TNET
TRINET GROUP, INC. Stock $tnet